
Vendors to Watch for Real-World Evidence, Data, Platforms, Technologies, and Consulting Services
Description
Vendors to Watch for Real-World Evidence, Data, Platforms, Technologies, and Consulting Services
This IDC Perspective reviews vendors to watch in the real-world evidence (RWE), data, platforms, technologies, and consulting and provides guidance to technology buyers."As the importance of RWD/RWE continues to grow exponentially, the life sciences industry is exploring a rapidly evolving landscape of well-established large players and a boiling cauldron of innovative start-ups. Vendors are also pulling out all the stops to ensure that they innovate and differentiate. Pharmas and biotechs are reevaluating legacy partnerships, looking at long-term strategic alignment, and recognizing that these are not easy decisions. Multiple criteria need to be examined, and the fact that these decisions can have a direct impact on regulatory approvals, costs, and time to market needs to be factored in when architecting a RWD/RWE strategy," said Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology, IDC.
Please Note: Extended description available upon request.
Table of Contents
7 Pages
- Executive Snapshot
- Situation Overview
- Advice for the Technology Buyer
- Learn More
- Related Research
- Synopsis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.